Just over 20 employees at Cambridge Antibody Technology’s Granta Park HQ are being made redundant as a result of owner AstraZeneca’s decision to combine CAT with AZ’s new biologics and vaccines business, Medimmune.
The Cambridge redundancies mainly affect management and support functions. The entire marketing department is being swept away and being handled from the US.
All non-scientific functions will be led from the US, but most functions will have some local representation and only communications has been completely axed.
More
No comments:
Post a Comment